Price Alert

PDS Biotechnology Corpora... (PDSB)

NASDAQ: PDSB · Real-Time Price · USD

1.20

0.00 (0.00%)

At close: Aug 15, 2025, 3:59 PM

1.22

1.66%

After-hours: Aug 15, 2025, 07:12 PM EDT

PDS Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	31.87M	39.98M	41.69M	49.75M	57.73M	66.63M	56.56M	54.25M	60.62M	65.2M	73.82M	71.64M	52.98M	58.88M	65.24M	69.74M	74.75M	25.04M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	4.27M	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	0.00	0.00	-0.00	0.00	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	2.49M	3.36M	2.38M	2.43M	2.05M	2.49M	2.59M	2.73M	2.77M	2.66M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	31.87M	42.47M	45.05M	52.13M	60.16M	68.69M	59.06M	56.84M	63.35M	67.97M	76.48M	74.41M	55.74M	60.73M	66.84M	71.34M	76.93M	27.26M
Property-Plant & Equipment	n/a	289.08K	304.21K	319.34K	334.47K	320.6K	335K	349.41K	403.3K	475.26K	527.53K	475.42K	258.19K	308.33K	357.7K	407.21K	456.34K	504.78K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	4.56M	304.21K	319.34K	334.47K	320.6K	335K	349.41K	403.3K	475.26K	527.53K	475.42K	258.19K	308.33K	357.7K	407.21K	456.34K	504.78K
Total Assets	40.48M	47.03M	45.36M	52.45M	60.5M	69.01M	59.39M	57.19M	63.75M	68.45M	77.01M	74.89M	56M	61.04M	67.2M	71.75M	77.39M	27.76M
Account Payables	n/a	2.86M	1.68M	1.3M	3.25M	6M	6.98M	5.37M	4.41M	2.07M	1.22M	2.04M	1.88M	2.75M	1.31M	1.45M	2.38M	950.6K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.37B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	12.5M	12.5M	12.5M	10.42M	7.29M	4.17M	54.54K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	640.07K	663.4K	3.1M	n/a	1.3M	1.14M	-54.54K	n/a	1.08M	n/a	n/a	0.00	1.23M	729.39K	0.00	n/a	n/a
Total Current Liabilities	n/a	18.27M	17.09M	18.34M	15.67M	15.06M	13.63M	9.15M	7.9M	4.13M	9.82M	4.84M	4.52M	5.02M	3.76M	3.58M	4M	2.93M
Long-Term Debt	n/a	6.35M	9.2M	12.03M	13.81M	16.65M	19.51M	23.41M	23.25M	23.14M	23.02M	22.91M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	6.4M	9.27M	12.11M	13.9M	16.76M	19.63M	23.55M	23.41M	23.31M	23.18M	22.99M	59.65K	146.98K	231.43K	313.98K	395.31K	458.29K
Total Liabilities	24.52M	24.67M	26.35M	30.45M	29.58M	31.82M	33.26M	32.7M	31.31M	27.44M	33.01M	27.83M	4.58M	5.17M	3.99M	3.89M	4.4M	3.39M
Total Debt	n/a	18.96M	21.83M	24.67M	24.38M	24.11M	23.85M	23.6M	23.52M	23.51M	23.47M	23.36M	394.66K	458.29K	490.35K	521.69K	552.98K	581.95K
Common Stock	n/a	15K	12.54K	12.15K	12.14K	12.1K	10.92K	10.23K	10.19K	10.14K	9.96K	9.39K	9.39K	9.39K	9.39K	9.38K	9.38K	7.35K
Retained Earnings	-200.03M	-190.6M	-182.11M	-174.16M	-163.43M	-155.1M	-144.5M	-133.6M	-122.75M	-111.22M	-101.56M	-82.42M	-75M	-69.18M	-60.7M	-54.38M	-47.42M	-46.83M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	-0.00	n/a	-0.00	0.00	n/a	n/a	0.00
Shareholders Equity	15.96M	22.36M	19M	22M	30.92M	37.18M	26.13M	24.48M	32.44M	41.01M	44M	47.06M	51.43M	55.87M	63.21M	67.86M	72.99M	24.37M
Total Investments	n/a	n/a	n/a	49.7B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a